Tongke Chen
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Correction: Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 29, 2026
Targeting sialic acid metabolism: a therapeutic strategy against gastric cancer driven by WZ35.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 12, 2025
Mitochondrial homeostasis in cancer: Functions and targeted therapies.
Journal: Critical reviews in oncology/hematology
Published: February 18, 2025
LonP1 Links Mitochondria-ER Interaction to Regulate Heart Function.
Journal: Research (Washington, D.C.)
Published: March 17, 2023
Identification of three metabolic subtypes in gastric cancer and the construction of a metabolic pathway-based risk model that predicts the overall survival of GC patients.
Journal: Frontiers in genetics
Published: November 10, 2022
SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: October 13, 2022
A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming.
Journal: Journal of translational medicine
Published: July 23, 2022
Curcumin micelles suppress gastric tumor cell growth by upregulating ROS generation, disrupting redox equilibrium and affecting mitochondrial bioenergetics.
Journal: Food & function
Published: April 30, 2020
The curcumin analogue WZ35 affects glycolysis inhibition of gastric cancer cells through ROS-YAP-JNK pathway.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: September 24, 2019
Last Updated: 09/26/2026